The content on this site is intended for healthcare professionals only
Research highlights in lung cancer
Treatment of anxiety and depression in cancer patients using intergtaive medicine
Updates from ASCO 2024 in gastrointestinal tumours
Research highlights in breast cancer
GIST tumours and soft tissue sarcomas
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Antibody drug conjugates coming to primetime and new agents for breast cancer
Intervention of osteoclastogenesis that occurs in breast cancer and multiple myeloma
Uncommon genetic aberrations NTRK, RET, NRG
Updates on triple negative breast cancer and immunotherapy
Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeutic regimen in mCRC
Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer
